Send to a Friend Font Size: Increase Decrease

31R and RVVTF Related Headlines

Nov 21, 2025 12:07PM Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
Sep 19, 2025 05:00PM Revive Therapeutics closes second tranche of private placement for $91,400
Sep 19, 2025 05:00PM Revive Therapeutics Announces Closing of Second Tranche of Private Placement

31R and RVVTF Related Press Releases

Nov 21, 2025 12:07PM Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
Sep 19, 2025 05:00PM Revive Therapeutics Announces Closing of Second Tranche of Private Placement

31R and RVVTF Related SEC Filings